AFP464 in Treating Patients With Advanced Solid Tumors

Summary

This phase I trial is studying the side effects and best dose of AFP464 in treating patients with advanced solid tumors. Drugs used in chemotherapy, such as AFP464, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Timeline

Start

2006-06

Primary completion

2011-01

Completion

—

Drugs

Indications